Accelerating Personalized Precision Medicine
UCLA Researchers Launch AI Tool for Cancer Therapy Screening
New technology uses 3D bioprinting and artificial intelligence to monitor patient tumor responses in real time.
A 3D bioprinter in a sterile laboratory setting generating small cellular structures with digital artificial intelligence interface overlays showing real-time data analysis.
Photo: Avantgarde News
Researchers at the UCLA Health Jonsson Comprehensive Cancer Center developed a platform to accelerate cancer therapy discovery [1]. The system integrates 3D bioprinting, high-speed imaging, and artificial intelligence to observe how patient-derived tumor organoids respond to drugs [2]. This innovation allows medical teams to track treatment efficacy in real time without using destructive assays [1][3].
The platform can test hundreds of potential therapeutic combinations simultaneously [1]. By utilizing advanced imaging and AI, clinicians can make more personalized treatment decisions for patients [2]. This approach significantly reduces the time required to identify effective therapies compared to traditional methods [3]. This technology represents a advancement in precision medicine and oncology [1][2].
Editorial notes
Transparency note
AI assisted drafting. Human edited and reviewed.
- AI assisted
- Yes
- Human review
- Yes
- Last updated
Risk assessment
Reviewed for sourcing quality and editorial consistency.
Sources
- 1.↗
uclahealth.org
https://www.uclahealth.org/news/release/new-ai-powered-platform-helps-researchers-find-promising
- 2.↗
bioengineer.org
https://bioengineer.org/ai-driven-platform-accelerates-discovery-of-promising-cancer-therapies/
- 3.↗
letsdatascience.com
https://letsdatascience.com/news/ucla-unveils-ai-platform-to-track-tumor-organoid-drug-respon-e672d73a
Related stories
View all
Topics
About the author
Avantgarde News Desk covers accelerating personalized precision medicine and editorial analysis for Avantgarde News.